Interferon system defects in human malignant melanoma

Cancer Res. 1995 Sep 15;55(18):4099-104.

Abstract

We have examined the ability of melanoma cell lines and normal human melanocytes, which have demonstrable intact IFN genes, to secrete both IFN-alpha and IFN-beta in response to induction with virus. Normal melanocytes were found to secrete both IFN-alpha and IFN-beta after virus induction. In contrast, although all but one of the melanoma lines tested were capable of secreting IFN-beta, none were capable of IFN-alpha secretion. This phenomenon was not due to defects in either translation of IFN-alpha mRNA or secretion of IFN-alpha proteins, since transfection of melanoma lines with a constitutive IFN-alpha 2b expression vector resulted in the secretion of high levels of IFN. On further examination, this inability to express natural IFN-alpha appeared to be due to a defect in activation of the IFN-alpha promoters, since constructs containing the IFN-alpha promotor were completely unresponsive to viral infection in melanoma cells but inducible in melanocytes. These results show that there is a specific disruption of IFN-alpha gene activation rather than IFN-beta in melanoma lines and suggest that this is due to disruption of a trans-acting IFN-alpha gene transcription factor. Disruption of this factor and its consequences may be important in the development of malignant melanoma.

MeSH terms

  • Base Sequence
  • Butyrates / pharmacology
  • Butyric Acid
  • Genes, Tumor Suppressor
  • Humans
  • Interferon-alpha / genetics*
  • Interferon-beta / genetics*
  • Melanoma / genetics*
  • Molecular Sequence Data
  • Promoter Regions, Genetic
  • Tumor Cells, Cultured

Substances

  • Butyrates
  • Interferon-alpha
  • Butyric Acid
  • Interferon-beta